Crewe Advisors’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-7
| Closed | -$27 | – | 818 |
|
|
2024
Q3 | $27 | Hold |
7
| – | – | ﹤0.01% | 712 |
|
|
2024
Q2 | $69 | Hold |
7
| – | – | ﹤0.01% | 934 |
|
|
2024
Q1 | $547 | Hold |
7
| – | – | ﹤0.01% | 905 |
|
|
2023
Q4 | $1.29K | Hold |
7
| – | – | ﹤0.01% | 309 |
|
|
2023
Q3 | $5.11K | Hold |
7
| – | – | ﹤0.01% | 285 |
|
|
2023
Q2 | $33.2K | Hold |
7
| – | – | ﹤0.01% | 304 |
|
|
2023
Q1 | $19.2K | Hold |
7
| – | – | ﹤0.01% | 443 |
|
|
2022
Q4 | $18.9K | Hold |
7
| – | – | ﹤0.01% | 435 |
|
|
2022
Q3 | $29K | Hold |
7
| – | – | 0.01% | 402 |
|
|
2022
Q2 | $19K | Buy |
+7
| New | +$19K | ﹤0.01% | 440 |
|